Advisory Alpha, LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 33 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 7.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
Advisory Alpha, LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2019$950,000
-52.5%
5,0000.0%0.00%
-100.0%
Q1 2019$2,000,0005,0000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Ion Asset Management Ltd. 4,035,008$1,796,0000.76%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 4,779,800$2,127,0000.04%
ANGELO GORDON & CO., L.P. 1,057,068$470,0000.04%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 4,000,000$1,780,000,0000.03%
Nine Chapters Capital Management LLC 21,300$9,0000.02%
FEDERATED HERMES, INC. 2,143,431$954,0000.00%
Harel Insurance Investments & Financial Services Ltd. 40,000$18,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,588$135,0000.00%
WEDBUSH SECURITIES INC 18,000$8,0000.00%
Spark Investment Management LLC 23,800$10,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders